Rogaratinib
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Rogaratinib, covering 2018-04-18 to 2025-04-09. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1b/2 Study of Rogaratinib (BAY1163877) in Combination With Atezolizumab in Urothelial Carcinoma [Phase 1]